Search Results - "Venstrom, Jeff"

Melanomas with activating RAF1 fusions: clinical, histopathologic, and molecular profiles by Williams, Erik A., Shah, Nikunj, Montesion, Meagan, Sharaf, Radwa, Pavlick, Dean C., Sokol, Ethan S., Alexander, Brian M., Venstrom, Jeff M., Elvin, Julia A., Ross, Jeffrey S., Tse, Julie Y., Mochel, Mark C.

“…A subset of melanomas is characterized by fusions involving genes that encode kinases. Melanomas with RAF1 fusions have been rarely reported, mostly in…”
Get full text

Melanoma with in-frame deletion of MAP2K1: a distinct molecular subtype of cutaneous melanoma mutually exclusive from BRAF, NRAS, and NF1 mutations by Williams, Erik A., Montesion, Meagan, Shah, Nikunj, Sharaf, Radwa, Pavlick, Dean C., Sokol, Ethan S., Alexander, Brian, Venstrom, Jeff, Elvin, Julia A., Ross, Jeffrey S., Williams, Kevin Jon, Tse, Julie Y., Mochel, Mark C.

“…While the genomics of BRAF, NRAS, and other key genes influencing MAP kinase (MAPK) activity have been thoroughly characterized in melanoma, mutations in…”
Get full text

Immune Characteristics of Chinese Diffuse Large B-Cell Lymphoma Patients: Implications for Cancer Immunotherapies by Xu, Peng-peng, Sun, Chun, Cao, Xu, Zhao, Xia, Dai, Hang-jun, Lu, Shan, Guo, Jian-jun, Fu, Shi-jing, Liu, Yu-xia, Li, Su-chun, Chen, Meng, McCord, Ron, Venstrom, Jeff, Szafer-Glusman, Edith, Punnoose, Elizabeth, Kiermaier, Astrid, Cheng, Gang, Zhao, Wei-li

“…Immunotherapeutic agents have demonstrated encouraging signs of clinical utility in non-Hodgkin lymphoma. The goal of this study is to analyze the immune…”
Get full text